Mogelijk gemaakt door Google TranslateTranslate
Oorspronkelijke tekst
Deze vertaling beoordelen
Je feedback wordt gebruikt om Google Translate te verbeteren
Latest Press Releases
View all
TimeHeadline
9m agoFatPipe Unveils VeloCloud Replacement Program with Price Match, 15% Discounts and 10% Partner Rebates
36m agoAngle Advisors announces Shift Transit has been recapitalized by Main Street Capital Corporation
36m agoCentury Complete Announces New Homes Coming Soon to Fleming Island, FL
36m agoSprott Physical Copper Trust Announces Preliminary Proxy Results for Unitholder Meeting and Anticipated Listing Date on the NYSE Arca
37m agoTambourine & Hyatt Launch Hyatt Wedding Guide to Revolutionize Digital Wedding Planning

Regenxbio Inc

About

Regenxbio Inc (NASDAQ:RGNX) — investor relations, events, news, and company updates on 6ix.

Latest News

Mar 11 2026
REGENXBIO REPORTS NEW POSITIVE INTERIM DATA FROM PHASE I/II AFFINITY DUCHENNE® TRIAL OF RGX-202
Mar 5 2026
REGENXBIO Reports Fourth Quarter and Full Year 2025 Financial Results and Operational Highlights
Mar 4 2026
REGENXBIO Announces Presentations at the 2026 Muscular Dystrophy Association (MDA) Clinical & Scientific Conference
Feb 25 2026
REGENXBIO to Host Conference Call on March 5 to Discuss Fourth Quarter and Full Year 2025 Financial Results and Operational Highlights
Feb 9 2026
REGENXBIO Announces Regulatory Update on RGX-121 BLA for MPS II

Financials

Revenue
$170.44 M
Market Cap
$440.26 M
EPS
-3.76

Community Chat

Ask AI

6ix6ixAIEvents